MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1536/ihj.18-339

Медицинская библиотека · International heart journal · 2019

Outcomes of Transcatheter Aortic Valve Implantation in Patients with Cirrhosis.

Higuchi Ryosuke, Tobaru Tetsuya, Hagiya Kenichi, Saji Mike, Mahara Keitaro, Takamisawa Itaru, Shimizu Jun, Iguchi Nobuo, Takanashi Shuichiro, Takayama Morimasa, Isobe Mitsuaki

СтатьяПеревод пока не подготовлен

Аннотация

Cirrhosis is a significant adverse factor of cardiac surgeries. Transcatheter aortic valve implantation (TAVI) has evolved as a less invasive therapy for aortic stenosis, whereas detailed case analysis of TAVI in cirrhotic patients is limited.Among 444 consecutive patients who underwent TAVI in the Sakakibara Heart Institute between October 2013 and January 2018, we retrospectively reviewed 11 patients (2.5%) with cirrhosis. All outcomes were defined according to the Valve Academic Research Consortium-2 criteria.The median age of the patients was 82 years, and eight (73%) were female. Seven patients (64%) were Child-Turcotte-Pugh class A, and four patients (36%) were class B. The Model for End-Stage Liver Disease score was 10 (7.0-13). TAVI was performed using Edwards SAPIEN XT/SAPIEN3 in nine patients (82%), and Medtronic CoreValve/Evolut R in two patients (18%), via transfemoral (n = 8, 73%) or transapical (n = 3, 27%) approach. The device success rate was 100% and no extracorporeal circulation had been inducted. No death, stroke, life-threatening bleeding, and acute kidney injury stage 2 or 3 occurred within 30 days, but three major bleeding events (27%) were documented (two access-site bleeding in transapical approach, and one pulmonary hemorrhage caused by transient mitral regurgitation). During a median follow-up of 493 days, four deaths had occurred, and the mid-term survival rate was 81% and 65% at one and two years each.TAVI is a promising therapeutic option for patients with cirrhosis. Further study should be needed regarding optimal patient selection and procedures in patients with cirrhosis.

Для цитирования: Higuchi Ryosuke, Tobaru Tetsuya, Hagiya Kenichi, Saji Mike, Mahara Keitaro, Takamisawa Itaru, Shimizu Jun, Iguchi Nobuo, Takanashi Shuichiro, Takayama Morimasa, Isobe Mitsuaki. Outcomes of Transcatheter Aortic Valve Implantation in Patients with Cirrhosis.. International heart journal. 2019. DOI: 10.1536/ihj.18-339.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.